| 1 (26) | Samsung Corp * | MUL |  |
| 2 (56) | AstraZeneca * | MUL | |
| 3 (61) | GlaxoSmithKline * | MUL | |
| 4 (77) | GlaxoSmithKline, United States | USA | |
| 5 (84) | Merck * | MUL | |
| 6 (92) | Hoffmann-La Roche Ltd, United States | USA | |
| 7 (96) | Boehringer Ingelheim * | MUL | |
| 8 (105) | Merck & Co Inc, United States | USA | |
| 9 (117) | Johnson & Johnson * | MUL | |
| 10 (118) | Janssen Biotech Inc | USA | |
| 11 (122) | Sanofi * | MUL | |
| 12 (124) | Sanofi, United States | USA | |
| 13 (128) | Janssen | MUL | |
| 14 (158) | Bristol-Myers Squibb Company * | MUL | |
| 15 (164) | F Hoffmann-La Roche * | MUL | |
| 15 (164) | Novartis * | MUL | |
| 17 (183) | Pfizer Inc, United States | USA | |
| 18 (190) | AstraZeneca, United States | USA | |
| 19 (192) | Pfizer * | MUL | |
| 20 (212) | Takeda Pharmaceuticals International Inc * | MUL | |
| 21 (214) | Shionogi & Co Ltd | JPN | |
| 22 (215) | Pfizer Inc, United Kingdom | GBR | |
| 23 (233) | Gilead Sciences * | MUL | |
| 23 (233) | Gilead Sciences Inc, United States | USA | |
| 25 (235) | GlaxoSmithKline, Belgium | BEL | |
| 26 (251) | Janssen Research & Development, LLC | BEL | |
| 27 (320) | AbbVie * | MUL | |
| 28 (321) | AbbVie Inc, United States | USA | |
| 29 (367) | Bayer * | MUL | |
| 30 (382) | GlaxoSmithKline, United Kingdom | GBR | |
| 31 (402) | RTI Health Solutions | USA | |
| 32 (417) | EMMES Corp | USA | |
| 33 (454) | Bayer AG, Germany | DEU | |
| 34 (467) | Manipal Global Education Group * | MUL | |
| 35 (475) | Aramco * | MUL | |
| 35 (475) | Saudi Arabian Oil Company | SAU | |
| 37 (572) | Abbott Laboratories * | MUL | |
| 38 (620) | Novo Nordisk * | MUL | |
| 39 (631) | Novo Nordisk A/S | DNK | |
|
